Published in Rev Neurol (Paris) on January 01, 1981
The Phantom in our opera - or the hidden ways of the autonomic nervous system in cardiac patients. Neth Heart J (2004) 0.86
Orthostatic hypotension associated with an epidermoid tumor of the IV ventricle. J Neurol (2009) 0.80
The Cushing response evoked by a fourth ventricular brainstem mass. Neurology (2014) 0.75
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet (2000) 2.97
Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke (2000) 2.59
Partially overlapping neural networks for real and imagined hand movements. Cereb Cortex (2000) 2.47
Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature (1997) 2.44
False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol (2000) 2.42
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg (2000) 2.25
Glioblastomas with an oligodendroglial component: a pathological and molecular study. J Neuropathol Exp Neurol (2001) 2.24
HSV-1 in brain and risk of Alzheimer's disease. Lancet (1998) 2.21
Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Respir Crit Care Med (1994) 2.19
Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron (1990) 2.09
Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol (1999) 2.02
Deficit of suppressor T cells in active multiple sclerosis. Lancet (1980) 1.83
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol (1994) 1.81
Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol (1997) 1.79
Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11. Am J Hum Genet (1999) 1.78
Are the brains of monozygotic twins similar? A three-dimensional MR study. AJNR Am J Neuroradiol (1998) 1.71
MR appearance of hypertrophic olivary degeneration after contralateral cerebellar hemorrhage. AJNR Am J Neuroradiol (1991) 1.69
Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 1.69
MR determination of hippocampal volume: comparison of three methods. AJNR Am J Neuroradiol (1996) 1.66
Alzheimer's disease: current knowledge, management and research. CMAJ (1997) 1.66
Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood (1996) 1.62
Neurological complications of neurofibromatosis type 1 in adulthood. Brain (1999) 1.58
Fulminating multiple sclerosis-like leukoencephalopathy revealing human immunodeficiency virus infection. Neurology (1991) 1.56
The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci (2000) 1.56
Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke? Stroke (2001) 1.53
Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res Mol Brain Res (1995) 1.50
Carotid artery stenosis: prospective comparison of CT, three-dimensional gadolinium-enhanced MR, and conventional angiography. Radiology (2001) 1.50
A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet (1976) 1.49
Facilitating submental endotracheal intubation with an endotracheal tube exchanger. Anesth Analg (2000) 1.49
Developmental abnormalities of the medial temporal lobe in patients with temporal lobe epilepsy. AJNR Am J Neuroradiol (1995) 1.49
Functional MR evaluation of temporal and frontal language dominance compared with the Wada test. Neurology (2000) 1.48
Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology (2002) 1.43
Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet (1985) 1.41
Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry (1998) 1.41
Unusual multicystic lesions of the brainstem are mesencephalo-thalamic expanding lacunae. Br J Neurosurg (1997) 1.40
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39
Flexion contractures revealing hypopituitarism. Eur J Med (1992) 1.39
Treatment of Guillain-Barré syndrome with interferon-beta. Lancet (1998) 1.39
Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry (1995) 1.38
Atypical MR presentation of Wilson disease: a possible consequence of paramagnetic effect of copper? Neuroradiology (1992) 1.38
Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg (2000) 1.35
Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis. Brain Res (1999) 1.31
MRI in cerebral venous thrombosis. J Neuroradiol (1994) 1.29
Acute myeloradiculitis due to cytomegalovirus as the initial manifestation of AIDS. J Neurol Neurosurg Psychiatry (1989) 1.29
Intracranial extra-axial cavernous (HEM) angiomas: tumors or vascular malformations? J Neuroradiol (2002) 1.29
Vertebral hemangiomas presenting with neurologic symptoms. Surg Neurol (1987) 1.28
Basal ganglia and supplementary motor area subtend duration perception: an fMRI study. Neuroimage (2003) 1.27
Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology (2004) 1.27
Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol (2002) 1.26
[Ultrastructure of hem- angioblastomas of the central nervous system]. Rev Neurol (Paris) (1968) 1.25
Hypertrophic cranial pachymeningitis: assessment with CT and MR imaging. AJNR Am J Neuroradiol (1989) 1.25
Asterixis in focal brain lesions. Arch Neurol (1979) 1.22
Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord (2000) 1.21
Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol (2008) 1.20
Presence of zinc, aluminum, magnesium in striopalledodentate (SPD) calcifications (Fahr's disease): electron probe study. Acta Neuropathol (1977) 1.20
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.20
OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet (2001) 1.19
Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neurology (1998) 1.19
Thalamic stimulation and proximal tremor. A specific target in the nucleus ventrointermedius thalami. Arch Neurol (1993) 1.18
Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis. AJNR Am J Neuroradiol (2001) 1.16
[Acute neuromyelitis optica and acute pulmonary tuberculosis (author's transl)]. Rev Neurol (Paris) (1980) 1.15
Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neurosci Lett (2002) 1.14
Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res (1999) 1.13
Motor neglect. J Neurol Neurosurg Psychiatry (1983) 1.12
Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res (1999) 1.12
Cerebral lacunae. A proposed new classification. Clin Neuropathol (1985) 1.11
Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem (1998) 1.11
Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. Brain Res Mol Brain Res (2001) 1.10
Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain (1996) 1.09
Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis (2000) 1.09
Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation. J Neurol Neurosurg Psychiatry (1994) 1.09
Adult polyglucosan body disease (APBD). J Neuropathol Exp Neurol (1988) 1.08
[Sinus bradycardia and sinoauricular block induced by carbamazepine]. Presse Med (1983) 1.07
The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res Brain Res Rev (1998) 1.07
Role of the supplementary motor area in motor deficit following medial frontal lobe surgery. Neurology (2001) 1.06
Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol (1994) 1.06
Percutaneous biopsies of the thoracic spine under CT guidance: transcostovertebral approach. J Comput Assist Tomogr (1990) 1.06
Three-dimensional computed tomographic angiography in detection of cerebral aneurysms in acute subarachnoid hemorrhage. Neurosurgery (1997) 1.06
Gadolinium-enhanced MR of chronic dural sinus thrombosis. AJNR Am J Neuroradiol (1995) 1.06
[Thalamic dementia. Expansive lacunae of the thalamo-paramedian mesencephalic area. Hydrocephalus caused by stenosis of the aqueduct of Sylvius]. Rev Neurol (Paris) (1983) 1.05
Transient myasthenia gravis during HIV infection. Muscle Nerve (1995) 1.04
Selective deficit of visual size perception: two cases of hemimicropsia. J Neurol Neurosurg Psychiatry (1994) 1.03
Cerebral aneurysms treated by Guglielmi detachable coils: evaluation with diffusion-weighted MR imaging. AJNR Am J Neuroradiol (2000) 1.02
Cytomegalovirus (CMV) encephalomyeloradiculitis and human immunodeficiency virus (HIV) encephalitis: presence of HIV and CMV co-infected multinucleated giant cells. Acta Neuropathol (1990) 1.02
[The astrocyte]. Nouv Presse Med (1972) 1.02
Complete spontaneous thrombosis of a giant intracranial aneurysm. Neuroradiology (1994) 1.02
Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol (2000) 1.02
Postoperative speech disorder after medial frontal surgery: role of the supplementary motor area. Neurology (2003) 1.01
[Neurofibromas in von recklinghausen's disease. Ultrastructural study and nosologic relation to neurinomas]. Acta Neuropathol (1968) 1.01
Role of the healthy hemisphere in recovery after resection of the supplementary motor area. Neurology (2004) 1.01